Clinion Named #1 Clinical Trial Management Solution Provider of 2023 by Medhealth Review

Austin, TX — November 08, 2023

Clinion has been named the #1 Clinical Trial Management Solution Provider of 2023 by Medhealth Review, recognizing the company’s leadership in advancing clinical trials with cutting-edge AI-enabled technology.

This recognition highlights Clinion’s commitment to a fully integrated eClinical platform that combines EDC, IWRS/RTSM, CTMS, ePRO, eConsent, CSR Automation, eProtocol Automation, and AI Medical Coding into a single, seamless system.

Clinion’s eClinical Platform harnesses artificial intelligence to generate actionable, data-driven insights that optimize study protocols and support informed decision-making. Designed to facilitate decentralized trials, it enables participants to engage remotely, improving accessibility and flexibility. With real-time monitoring, robust security, and seamless team collaboration, Clinion provides a unified solution covering every stage of a clinical trial, from start-up through close-out.

This recognition reaffirms Clinion’s mission to advance clinical research, accelerate trial timelines, and bring new therapies to patients more efficiently. It also reflects the dedication of Clinion’s team and the support of its clients, which have been instrumental in driving innovation in eClinical solutions.

Read The Full Story Here

If you are interested in learning more about Clinion and our innovative clinical trial management solutions. Contact us today.